Brexit: EC reminder on batch testing transfer of medicinal products to EU by 2020
From today’s perspective, the UK will be a third country as of 1 November 2019. As a result, all batch testing facilities will have to be fully transferred to the EU27/EEA by 1 January 2020. The European Commission has now published a reminder announcement regarding the requirement of batch release sites to be established in the EU. This applies also to MAHs which were granted an exemption to continue relying on quality control testing performed in the UK earlier this year (we reported).
Marketing authorization holders (MAHs) need to ensure that "all necessary steps have been taken to prepare the transfer of the quality control testing site to the EU27. Marketing authorisation holders must confirm and set out their precise timetable for transfer of the quality control testing site,” the reminder announcement says.
This should allow the process to be completed quickly and in principle by the end of 2019 at the latest.
You can follow the latest regulatory developments on Brexit visiting this EMA website.